GSK Investigational Site
Dubrovnik 20000
0 studies enrolling now · 2 studies all time
What they study most
Alzheimer's Disease, Asthma
Studies at this site
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
— Completed
Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
— Completed